TGFB1 and metabolic dysfunction-associated steatohepatitis: Notably, EC-specific ablation of MLKL effectively attenuates liver fibrosis in NASH by blocking necroptosis and mitigating the TGFβ/Smad 2/3 signaling axis between endothelial cells and HSCs.